GSK, a biopharma company, has set ambitious ESG goals with a focus on reducing scope 3 emissions. As part of the Energize program, a collaborative effort across pharmaceutical companies to help suppliers lower their carbon impact, GSK calls on its long-standing partnership with Schneider Electric to enable business continuity and achieve a competitive position for energy buying programs.
Other content in this Stream
Learn how Schneider Electric is working with companies like PepsiCo, Walmart, GSK, and Amy's Kitchen to drive sustainability across their supply chains — and ours.
Energize is helping to drive system-level change with the hope of inspiring other industry sectors to follow suit.
Amgen and Bristol Myers Squibb join ten other pharmaceutical companies to help accelerate the adoption of renewable energy and reduce greenhouse gas emissions within the pharmaceutical value chain.
Charles River Laboratories International, Inc. announced a wind energy contract with Repsol to address the entirety of the Company’s European power requirements with renewable energy by 2023.
GSK and Novartis talk about the goal of the Energize supply chain decarbonization program and the potential to scale this model to other sectors.
The Energize supply chain decarbonization program brings together leading pharmaceutical companies to collaborate on reducing their Scope 3 emissions.
Schneider Electric hosts a roundtable with several participating companies in the Energize pharmaceutical supply chain collaboration at COP26 in Glasgow.
Today, 10 leading pharmaceutical companies announced a ground-breaking collaboration to increase access to renewables for their suppliers. Read their letter to learn how suppliers can register.
Schneider Electric and Carnstone announce Energize – a program between global pharmaceutical companies to engage suppliers in bold climate action and decarbonization of the pharmaceutical value chain.
With Schneider Electric's advisory support, Johnson & Johnson has executed three separate virtual power purchase agreements (VPPAs) in Europe.
With Schneider Electric's help, Charles River Labs has signed a long-term solar energy contract to address all of its North American electric power requirements.
Sanofi shares its success story of getting beyond the low-hanging fruit and growing enterprise efficiency from a site-by-site endeavor to a programmatic approach.
Takeda Pharmaceutical has executed renewable energy and carbon offset contracts to address 100% of its FY19 Scope 1, 2, and 3 emissions, inclusive of its supply chain.
The fully integrated approach spans energy management, resource efficiency, renewable energy procurement, carbon offsetting, value chain decarbonization, and AI-driven data collection and disclosure.
With the announcement of a Biden win, our experts take a closer look at how the new administration’s plans may impact your company’s energy and sustainability strategies.
In part II of this blog series, let’s dive deeper into a real life scenario of how one company approached stakeholder engagement on Scope 3.
With companies making bolder energy & sustainability commitments, many comms teams are now tasked with managing complex messaging. With the stakes so high, here are 5 tips to ensure you nail it.
Using an innovative approach that combines wind and solar technology, DaVita Inc is on track to reach its 100% renewable energy goal by 2022.
With an integrated, data-driven approach to energy & carbon management, a global healthcare organization cut emissions and saved more than €2 million in the process.
Learn how a global pharmaceutical overcomes site-based hurdles to industrialize efficiency and accelerate progress towards its corporate sustainability goals.